Key stats
About HARVEST HEALTHCARE LEADERS INCM ETF CLASS A UNITS
Home page
Inception date
Nov 19, 2014
Structure
Canadian Mutual Fund Trust (ON)
Dividend treatment
Distributes
Distribution tax treatment
Ordinary income
Income tax type
Capital Gains
Primary advisor
Harvest Portfolios Group, Inc.
The fund actively managed portfolio starts with its investable universe, which consists of developed market healthcare companies whose market capitalization is at least $5 billion USD at the time of investment, and who meet the fund providers proprietary investment characteristics. The fund then equally weights the top 20 companies the adviser perceives as Healthcare Leaders from the universe. Quantitative factors such as yield, earnings per share growth, implied volatility and option liquidity are also considered when composing the portfolio. HHL aims to achieve (i) an average P/E ratio lower than the average of the investable universe, and (iii) an average 5-year ROE growth greater than the average of the universe. The fund also writes covered call options on up to 33% of the portfolio holdings to decrease volatility. Fund reconstitution and rebalancing is done quarterly.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks97.38%
Health Technology87.83%
Health Services9.55%
Bonds, Cash & Other2.62%
Miscellaneous1.67%
ETF1.18%
Cash0.75%
Rights & Warrants−0.99%
Stock breakdown by region
North America85.22%
Europe14.78%
Latin America0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
HHL invests in stocks. The fund's major sectors are Health Technology, with 87.83% stocks, and Health Services, with 9.55% of the basket. The assets are mostly located in the North America region.
HHL top holdings are Regeneron Pharmaceuticals, Inc. and Eli Lilly and Company, occupying 5.10% and 4.93% of the portfolio correspondingly.
HHL last dividends amounted to 0.06 CAD. The month before, the issuer paid 0.06 CAD in dividends,
HHL assets under management is 1.35 B CAD. It's risen 4.23% over the last month.
HHL fund flows account for 228.47 M CAD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
Yes, HHL pays dividends to its holders with the dividend yield of 9.97%. The last dividend (May 9, 2025) amounted to 0.06 CAD. The dividends are paid monthly.
HHL shares are issued by Harvest Portfolios Group, Inc. under the brand Harvest ETFs. The ETF was launched on Nov 19, 2014, and its management style is Active.
HHL expense ratio is 1.06% meaning you'd have to pay 1.06% of your investment to help manage the fund.
HHL follows the No Underlying Index. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
HHL invests in stocks.
HHL price has fallen by −1.65% over the last month, and its yearly performance shows a −16.39% decrease. See more dynamics on HHL price chart.
NAV returns, another gauge of an ETF dynamics, showed a −8.63% decrease in three-month performance and has decreased by −7.40% in a year.
NAV returns, another gauge of an ETF dynamics, showed a −8.63% decrease in three-month performance and has decreased by −7.40% in a year.
HHL trades at a premium (0.17%) meaning the ETF is trading at a higher price than the calculated NAV.